So far, Pathways has cost state and federal taxpayers nearly $9,000 per enrollee, largely back-end costs to run the program.
Fred Hutch’s Phase 2 study among blood cancer patients is a “gamechanger” in preventing graft-versus-host disease after ...
Deep funding cuts and staff layoffs threaten current and future research on cancer, liver disease, HIV, COVID and other ...
Prostate cancer blogger Dan Zeller shares an item that had him LOLing. Okay. Now I’ve seen everything. This ad for prostate ...
The scientist studies data on gender identity and sexual orientation. Here’s why that’s vital for cancer research and health ...
Preventing the cell’s protein factories from making the cancer-causing protein MYC could stop out-of-control tumors.
National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...
The American Association for Cancer Research (AACR) is deeply concerned that the Administration’s recent actions are threatening the National Institutes of Health (NIH) and its lifesaving mission to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results